Launched in 2006, DomaniCell is a national pioneer in the field of stem cell collection and storage providing innovative family cord blood banking services through hospital partner programs across the country.

The DomaniCell Advantage is cGMP-compliant banking that few banks offer.  To learn more, click here.

The other unique DomaniCell program is its partnership with hospitals creating hospital-based turnkey cord blood banking programs.  Leading hospitals partner with DomaniCell to develop their own cord blood stem cell banking program that is built on DomaniCell infrastructure and technology. DomaniCell brings to its hospital clients a unique turn-key service that results in a hospital private-branded cord blood program establishing a new obstetrical program that generates a new source of revenue.

Setting it apart from other private cord blood banking programs, DomaniCell's partner hospitals are invested in the success of their program in a way that ensures the highest quality and standards and maximizes the opportunity.

As a member of the Progenitor Cell Therapy group of companies, DomaniCell is uniquely positioned to leverage internal scientific, manufacturing, and clinical expertise to benefit its partners and clientele.

ESTABLISHED:  DomaniCell LLC was incorporated as a wholly-owned subsidiary of Progenitor Cell Therapy LLC in 2005.

FINANCIAL:  Privately held

FINANCIAL STABILITY:  DomaniCell, LLC is a wholly-owned subsidiary of Progenitor Cell Therapy, LLC (www.progenitorcelltherapy.com). Founded in 1997 by medical and scientific leaders in the cell therapy field, privately-held Progenitor Cell Therapy, also known as PCT, has become the leading provider of cell therapy support services to its client companies worldwide from its state-of-the-art clean room facilities and laboratories in the United States. PCT has performed over 15,000 cell-based procedures since its operations began.

An ever-increasing roster of cell therapy companies and leading stem cell transplantation programs rely on PCT services.  The company has served over 100 clients, performed over 30,000 cell therapy procedures involving over 17,000 units of 20+ different kinds of cell-based products, approximately 5,000 of which have already been used for patient treatment.

Headquartered in New Jersey, with a present valuation of over $50 million, Progenitor Cell Therapy and its subsidiary, DomaniCell, is a profitable and stable company on a solid financial footing. Each parent choosing to DomaniCell to collect and store their baby’s cord blood stem cells, can share in the same confidence expressed in PCT by its institutional investors and some of the world’s foremost cell therapy companies which entrust the development of their products to Progenitor Cell Therapy.

WEBSITE:  www.domanicell.com

CONTACT:
  DomaniCell, LLC
  155 State Street
  Hackensack, New Jersey 07601
  Telephone: 888-8DO-MANI 
  Fax: 877-884-9661 
  info@domanicell.com

LOCATIONS:
  Headquarters - Corporate
  21 Main Street, Court Plaza South
  East Wing, Suite 304
  Hackensack, New Jersey 07601
  USA

East Coast Laboratory Facility
  20 Prospect Avenue Suite #400
  Hackensack, New Jersey 07601
 USA

West Coast Laboratory Facility
  291 N. Bernardo Avenue
  Mountain View, California 94043
  USA

QUESTIONS?  1-888-8DO-MANI